Söndag 22 December | 04:12:04 Europe / Stockholm
Svenska | English

Brain+

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (DKK).

Likviditet under dagen för detta pressmeddelande

Kalender

Tid*
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-16 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2024-05-15 - Årsstämma
2024-05-07 - Bokslutskommuniké 2023
2023-10-11 - Extra Bolagsstämma 2023
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2023-05-26 - Årsstämma
2023-04-28 - Bokslutskommuniké 2022
2022-09-29 - Kvartalsrapport 2022-Q2
2022-09-02 - Extra Bolagsstämma 2022
2022-05-19 - X-dag ordinarie utdelning BRAINP 0.00 DKK
2022-05-18 - Årsstämma
2022-04-29 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriVård & Omsorg
Brain+ är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom forskning och utveckling för behandling av demens och alzheimers. Produktportföljen inkluderar exempelvis kognitiv stimuleringsterapi. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs med störst närvaro inom Europa. Brain+ har sitt huvudkontor i Köpenhamn.
Invitation to Investor Webinar on Tues 3 Sept 2024 at 16:00 CEST: H1 2024 report and new Chief Commercial Officer
2024-08-30 12:35:56
Copenhagen, Denmark, 30. August 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Sign-up here (https://app.stokk.io/app/brain/event/171/h1-presentation-new-cco/) At the webinar, Brain+ will present its recently released H1 2024 report, including upcoming milestones and commercial outlook for the company in the UK. The webinar is an opportunity to meet new Chief Commercial Officer Devika Wood and will also be hosted by CEO and founder Kim Baden-Kristensen and CFO Hanne Vissing Leth.

Half-year 2024 report & presentation by new Chief Commercial Officer

3 Sept 2024 at 16:00 CEST – A replay of the webinar will be available after the meeting

Brain+ invites its shareholders as well as other investors and stakeholders to attend a webinar, which will take place on Tuesday, 3 September 2024 at 16:00 CEST.

Notably, participants in the webinar will have the opportunity to meet the new Chief Commercial Officer, Devika Wood, who will present herself and discuss the commercial plans and outlook for the company in the UK and take questions. Devika will be instrumental in executing Brain+’ UK focused strategy to reach proof-of-business and recurring sales.

CEO and founder Kim Baden-Kristensen and CEO Hanne Vissing Leth will present the company’s Half Year Report for 2024, which was released on 29 August 2024, and take questions.

Link to sign up for the Brain+ webinar and pre-submit questions

Contact Information

CEO and Co-founder: Kim Baden-Kristensen, + 45 31 39 33 17 (SMS), kim@brain-plus.com

Brain+ mission: Become the preferred provider of certified health tech solutions for better dementia management, servicing one million people affected by dementia by 2030.

Källa Cision
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden